Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods
E. Kransdorf(Cedars-Sinai Medical Center), Josef Stehlik(Intermountain Medical Center), Manreet Kanwar(University of Chicago), M’hamed Temkit(Phoenix Children's Hospital), Natasha A. Loghmanpour(Carnegie Mellon University)
Cited by 18
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283
Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support
|Circulation|2019|213
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024
|The Journal of Heart and Lung Transplantation|2024|179